TrialInternational journal of molecular sciences2025

Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study.

László Imre Tóth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.